Tein-yao Y. Chang
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Erratum for Hsu et al., "Evaluating the susceptibility of various common cell lines and assessing inactivation conditions to Mpox virus".
Journal: Microbiology spectrum
Published: February 05, 2026
Evaluating the susceptibility of various common cell lines and assessing inactivation conditions to Mpox virus.
Journal: Microbiology spectrum
Published: November 11, 2025
Study of lug Operon, SCCmec Elements, Antimicrobial Resistance, MGEs, and STs of Staphylococcus lugdunensis Clinical Isolates Through Whole-Genome Sequencing.
Journal: International journal of molecular sciences
Published: May 07, 2025
Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studies.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 17, 2025
Synergistic antiviral potential of N-(2-hydroxy)propyl-3-trimethylammoniumchitosan-functionalized silver nanoparticles with oseltamivir against influenza A viruses.
Journal: International journal of biological macromolecules
Published: May 09, 2024
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir.
Journal: Antimicrobial agents and chemotherapy
Published: March 06, 2024
Development of an EBOV MiniG plus system as an advanced tool for anti-Ebola virus drug screening.
Journal: Heliyon
Published: August 03, 2023
Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 30, 2022
Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model.
Journal: Frontiers in immunology
Published: October 26, 2022
Orally delivered perilla (Perilla frutescens) leaf extract effectively inhibits SARS-CoV-2 infection in a Syrian hamster model.
Journal: Journal of food and drug analysis
Published: December 16, 2021
A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant.
Journal: EMBO molecular medicine
Published: October 18, 2021
Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice.
Journal: International journal of biological macromolecules
Published: August 31, 2021
Last Updated: 09/26/2026